[HTML][HTML] Propionate supplementation promotes the expansion of peripheral regulatory T-Cells in patients with end-stage renal disease

F Meyer, FS Seibert, M Nienen, M Welzel… - Journal of …, 2020 - Springer
Patients with end-stage renal disease (ESRD) suffer from a progressively increasing low-
grade systemic inflammation, which is associated with higher morbidity and mortality …

Propionate supplementation promotes the expansion of peripheral regulatory T-Cells in patients with end-stage renal disease

F Meyer, FS Seibert, M Nienen, M Welzel… - 2020 - hss-opus.ub.ruhr-unibochum.de
Patients with end-stage renal disease (ESRD) suffer from a progressively increasing low-
grade systemic inflammation, which is associated with higher morbidity and mortality …

Propionate supplementation promotes the expansion of peripheral regulatory T-Cells in patients with end-stage renal disease

F Meyer, FS Seibert, M Nienen, M Welzel… - 2020 - hss-opus.ub.ruhr-uni-bochum.de
Patients with end-stage renal disease (ESRD) suffer from a progressively increasing low-
grade systemic inflammation, which is associated with higher morbidity and mortality …

[HTML][HTML] Propionate supplementation promotes the expansion of peripheral regulatory T-Cells in patients with end-stage renal disease

F Meyer, FS Seibert, M Nienen, M Welzel… - Journal of …, 2020 - ncbi.nlm.nih.gov
Patients with end-stage renal disease (ESRD) suffer from a progressively increasing low-
grade systemic inflammation, which is associated with higher morbidity and mortality …

Propionate supplementation promotes the expansion of peripheral regulatory T-Cells in patients with end-stage renal disease.

F Meyer, FS Seibert, M Nienen, M Welzel… - Journal of …, 2020 - europepmc.org
Patients with end-stage renal disease (ESRD) suffer from a progressively increasing low-
grade systemic inflammation, which is associated with higher morbidity and mortality …

Propionate supplementation promotes the expansion of peripheral regulatory T-Cells in patients with end-stage renal disease

F Meyer, FS Seibert, M Nienen… - Journal of …, 2020 - pubmed.ncbi.nlm.nih.gov
Patients with end-stage renal disease (ESRD) suffer from a progressively increasing low-
grade systemic inflammation, which is associated with higher morbidity and mortality …

Propionate supplementation promotes the expansion of peripheral regulatory T-Cells in patients with end-stage renal disease.

F Meyer, FS Seibert, M Nienen, M Welzel… - Journal of …, 2020 - europepmc.org
Patients with end-stage renal disease (ESRD) suffer from a progressively increasing low-
grade systemic inflammation, which is associated with higher morbidity and mortality …